Product
Active Control Placebo
1 clinical trial
1 indication
Indication
Healthy Control ParticipantsClinical trial
A Randomized, Double-blind, Double-dummy, Placebo-controlled, Three-way Crossover Study in Healthy Subjects to Evaluate the Next-day Residual Effects of 20 mg TasimelteonStatus: Completed, Estimated PCD: 2018-08-28